Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing

Although traditional approaches to biomarker discovery have elucidated key molecular markers that have improved drug selection (precision medicine), the discovery of biomarkers that inform optimal dose selection (precision dosing) continues to be a challenge in many therapeutic areas. Larger and mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Oni‐Orisan, Akinyemi, Srinivas, Nithya, Mehta, Krina, Das, Jesmin Lohy, Nguyen, Thu T., Tison, Geoffrey H., Bauer, Scott R., Burian, Maria, Funk, Ryan S., Graham, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Position Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212753/
https://www.ncbi.nlm.nih.gov/pubmed/33421282
http://dx.doi.org/10.1111/cts.12973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212753/
https://www.ncbi.nlm.nih.gov/pubmed/33421282
http://dx.doi.org/10.1111/cts.12973

Ejemplares similares